PCM Encore’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$98.4K Buy
+23,829
New +$80.8K 0.02% 445

Other funds holding RXRX

PCM Encore's RXRX Position: Q3 2026 in Review

PCM Encore opened a new position in Recursion Pharmaceuticals (RXRX) in Q3 2026: 23,829 shares worth $98.4K. The stake represents 0.02% of the portfolio and ranks #445 among its holdings.

354 funds tracked by Wall St. Rank hold RXRX as of Q3 2026.

  • PCM Encore held 23,829 shares of Recursion Pharmaceuticals worth $98.4K as of Q3 2026.
  • Recursion Pharmaceuticals was a new PCM Encore position in Q3 2026.
  • Recursion Pharmaceuticals made up 0.02% of PCM Encore's portfolio in Q3 2026, its #445 holding.
  • 354 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q3 2026.

Based on PCM Encore's 13F filing for Q3 2026, filed 19 Nov 2026.